Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease.

Bellanti R. et al, (2023), J Neurol Neurosurg Psychiatry

Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation

Keddie S. et al, (2023), Brain

AL amyloidosis presenting with isolated lumbosacral radiculoplexus neuropathy

Bellanti R. et al, (2023), Practical Neurology

Peripherin is a biomarker of axonal damage in peripheral nervous system disease

Keddie S. et al, (2023), Brain

Treatment of CIDP

Fehmi J. et al, (2023), Practical Neurology, 23, 46 - 53

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

Cheung A. et al, (2018), Heart Asia, 10, e010970 - e010970

Pericardial actinomycosis in a patient with oesophageal dysmotility and autoantibodies

Bellanti R. et al, (2017), British Journal of Hospital Medicine, 78, 472 - 473

Include forthcoming?